Natural Alternatives International, Inc.
Rank #437StartupNAII · Nasdaq · Consumer Defensive
Natural Alternatives International, Inc. (NAII) — Rank #437 by gross profitability (GP/assets 0.06) · ROE -21.5% · Piotroski F-Score N/A.
As-of 2026-09-28 · CIK 0000787253 · all metrics point-in-time as of the filing date.
About
Natural Alternatives International, Inc. engages in formulating, manufacturing, and marketing nutritional supplements in the United States and internationally.
Show moreShow less
It operates through two segments: Private-Label Contract Manufacturing, and Patent and Trademark Licensing. The company offers private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal, and other nutritional supplements, as well as other health care products. It also provides strategic partnering services, such as customized product formulation, clinical study design and support, manufacturing, marketing support, international regulatory and label law compliance, international product registration, packaging in multiple formats and labeling design, scientific research, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, marketing management, packaging and delivery system design, regulatory review, and international product registration assistance. In addition, the company sells beta-alanine ingredient under the CarnoSyn, TriBsynm, and SR CarnoSyn names. The company manufactures products in various forms, including capsules, tablets, chewable wafers, and powders. Its private-label contract manufacturing customers include companies that market nutritional supplements through direct sales marketing channels, direct to consumer e-commerce channels, and retail stores. Natural Alternatives International, Inc.
was founded in 1980 and is headquartered in Carlsbad, California.
- Industry
- Packaged Foods
- Sector
- Consumer Defensive
- State
- DE
- Filer Category
- Non-accelerated filerSmaller reporting company
- Fiscal Year End
- June 30
- Website
- nai-online.com
Financials
Each fiscal year is read as-of that year’s own 10-K filing, so nothing restated after the fact leaks backwards. Line items this filer never tagged are omitted. Hover or tap a badge for the diagnostic behind it.
| Fiscal year end | 2025-06-30filed 2025-09-23 | 2024-06-30filed 2024-09-27 | 2023-06-30filed 2023-09-21 | 2022-06-30filed 2022-09-21 |
|---|---|---|---|---|
| Revenue | 129.9 | 113.8 | 154.0 | 171.0 |
| Revenue growth (YoY) | 14.1% | -26.1% | -9.9% | -4.2% |
| Cost of revenue | 120.6 | 106.9 | 135.9 | 140.5 |
| Gross profit | 9.3 | 6.9 | 18.2 | 30.5 |
| Gross margin | 7.2% | 6.0% | 11.8% | 17.8% |
| Selling, general & administrative | — | — | — | — |
| Research & development | 1.8 | 1.9 | 2.1 | 2.5 |
| Operating income | (8.7) | (8.5) | 4.7 | 13.7 |
| Operating margin | -6.7% | -7.5% | 3.1% | 8.0% |
| Interest income | 0.2 | 0.2 | 0.0 | 0.0 |
| Pre-tax income | (10.7) | (9.5) | 3.6 | 13.7 |
| Income tax expense | 2.8 | (2.2) | 1.0 | 2.9 |
| Net income | (13.6) | (7.2) | 2.5 | 10.7 |
| Net margin | -10.5% | -6.3% | 1.6% | 6.3% |
| EPS (basic) | -$2.28 | -$1.23 | $0.43 | $1.75 |
| EPS (diluted) | -$2.28 | -$1.23 | $0.43 | $1.74 |
Figures are as originally filed with the SEC (point-in-time), not restated, so they can differ slightly from sites that show later-restated numbers. Why point-in-time?